{"brief_title": "Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED)", "brief_summary": "The purpose of this study is to determine the safety and efficacy of an investigational drug in patients with type 2 diabetes mellitus.", "condition": "Diabetes Mellitus, Type II", "intervention_type": "Drug", "intervention_name": "Pioglitazone", "description": "Pioglitazone 15 mg once daily, for patients not meeting specific glycemic goals during the placebo-controlled treatment period [Phase A], from Visit 5 (Week 6) to Visit 8 (Week 24)", "arm_group_label": "Placebo / Glipizide 5 mg", "other_name": "ACTOS", "criteria": "Inclusion Criteria: - Patients with type 2 diabetes mellitus", "gender": "All", "minimum_age": "18 Years", "maximum_age": "78 Years", "healthy_volunteers": "No", "id": "NCT00086515.xml"}